Drug class
Thioxanthene antipsychotic; dopamine D2 receptor antagonist
Mechanism of action
Antagonises dopamine D2 receptors in central dopaminergic pathways, reducing psychotic symptoms. It also has histamine H1, alpha-adrenergic and muscarinic receptor antagonism that contributes to sedative and autonomic effects.
General use cases
- Treatment of schizophrenia and other psychotic disorders in countries where chlorprothixene remains authorised; use and availability are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
